Her main research concerns Pathology, Glioma, Internal medicine, Astrocytoma and Surgery. Her Pathology research includes themes of Cancer and Central nervous system disease. When carried out as part of a general Glioma research project, her work on Anaplastic astrocytoma is frequently linked to work in Propidium iodide, therefore connecting diverse disciplines of study.
She has included themes like Gastroenterology, Endocrinology and Oncology in her Internal medicine study. Her Oncology research integrates issues from Concordance, Oligodendroglioma and Phases of clinical research. Her study in the field of Retrospective cohort study, Survival rate and Radiation therapy is also linked to topics like Hazard ratio.
Caterina Giannini focuses on Pathology, Internal medicine, Glioma, Oncology and Surgery. Her work on Pathology is being expanded to include thematically relevant topics such as Magnetic resonance imaging. Internal medicine is closely attributed to Gastroenterology in her research.
The study incorporates disciplines such as Brain tumor and Germline in addition to Glioma. Caterina Giannini interconnects Newly diagnosed and Glioblastoma in the investigation of issues within Oncology. Her Astrocytoma research incorporates themes from IDH1 and ATRX.
Caterina Giannini mainly focuses on Pathology, Internal medicine, Cancer research, Glioma and Oncology. Her research in Pathology intersects with topics in Metastasis and Ischemic injury. Her research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Neurofibromatosis, Overall survival, Nerve sheath tumor and Malignancy.
Her work on Glioblastoma and Pilocytic astrocytoma as part of her general Cancer research study is frequently connected to Tert promoter mutation, thereby bridging the divide between different branches of science. Her Glioma research is multidisciplinary, incorporating perspectives in Brain tumor, Cancer, Germline and ATRX. Her Oncology research is multidisciplinary, relying on both Young adult, Resection, Proportional hazards model and Oligodendroglioma.
Her primary areas of study are Internal medicine, Grading, Pathology, Glioma and World health. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology. Her biological study spans a wide range of topics, including Solitary fibrous tumor, Hemangiopericytoma, Radiology, Metastasis and Necrosis.
Her Pathology research is multidisciplinary, incorporating elements of Ischemic injury and 1p/19q Codeletion. Glioma is a subfield of Cancer research that Caterina Giannini explores. The various areas that she examines in her Cancer research study include Sonic hedgehog, Gene and PTEN.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D. Brown;Paul D. Brown;Karla V. Ballman;Karla V. Ballman;Jane H. Cerhan;S. Keith Anderson.
Lancet Oncology (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock.
Cancer Cell (2017)
Primary central nervous system vasculitis: analysis of 101 patients.
Carlo Salvarani;Robert D. Brown;Kenneth T. Calamia;Teresa J. H. Christianson.
Annals of Neurology (2007)
Pathology of Peripheral Nerve Sheath Tumors: Diagnostic Overview and Update on Selected Diagnostic Problems
Fausto J. Rodriguez;Andrew L. Folpe;Caterina Giannini;Arie Perry.
Acta Neuropathologica (2012)
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
J. Gregory Cairncross;Meihua Wang;Robert B. Jenkins;Edward G. Shaw.
Journal of Clinical Oncology (2014)
Pleomorphic xanthoastrocytoma: What do we really know about it
Caterina Giannini;Bernd W. Scheithauer;Peter C. Burger;Daniel J. Brat.
Pathologic alterations in the diabetic neuropathies of humans: a review.
Peter James Dyck;Caterina Giannini.
Journal of Neuropathology and Experimental Neurology (1996)
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Evanthia Galanis;Kurt A. Jaeckle;Matthew J. Maurer;Joel M. Reid.
Journal of Clinical Oncology (2009)
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
Karla V. Ballman;Jan C. Buckner;Paul D. Brown;Caterina Giannini.
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Kenneth D. Aldape;Karla Ballman;Alfred Furth;Jan C. Buckner.
Journal of Neuropathology and Experimental Neurology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: